EGFR and non-small cell lung carcinoma: The reinforcement learning (RL) algorithm was subsequently used to develop a web application called the “EGFR Mutant NSCLC Treatment Advisory System”, intended for experimental clinical use and accessible at “https://egfr-recommender.streamlit.app/, accessed on 6 January 2025”.